NCT02035800View on ClinicalTrials.gov

Bone Resorption, Osteoclastogenesis and Adalimumab

PHASE4UnknownINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions

RheumatoId Arthritis

Interventions

DRUG

Adalimumab

Patient will received medication as standard of care

Trial Locations (1)

J1H 5N4

RECRUITING

CRC Étienne Le-Bel at CHUS, Sherbrooke

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AbbVie

INDUSTRY

lead

Université de Sherbrooke

OTHER